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Abstract
Background: Carotid intima-media thickness (IMT), indices of large artery stiffness and measures of endothelium
function may be used as markers of early atherosclerosis in type 1 diabetes mellitus (T1DM). The aim of the
present study was to compare the indices of large artery structure and function as well as endothelial function and
regenerating capacity between adolescents with T1DM and healthy control of similar age. In addition, the
associations of different vascular measures with endothelial progenitor cells (EPCs), glyco-metabolic control and
serum levels of advanced glycation endproducts (AGEs), soluble receptors for AGEs (sRAGE) and adiponectin were
evaluated.
Methods: Sixteen uncomplicated young T1DM patients (mean age 18 ± 2 years, history of disease 11 ± 5 years,
HbA1c 7.7 ± 1.1%) and 26 controls (mean age 19 ± 2 years) were studied. A radiofrequency-based ultrasound
system (Esaote MyLab 70) was used to measure carotid IMT and wave speed (WS, index of local stiffness),
applanation tonometry (PulsePen) was applied to obtain central pulse pressure (PP) and augmentation index (AIx),
and carotid-femoral pulse wave velocity (PWV, Complior) was used as index of aortic stiffness. Peripheral
endothelium-dependent vasodilation was determined as reactive hyperemia index (RHI, EndoPAT). Circulating EPCs,
glycometabolic profile, AGEs (autofluorescence method), sRAGE and adiponectin were also measured.
Results: After adjusting for age, sex and blood pressure, T1DM adolescents had significantly higher carotid IMT (456 ±
7 vs. 395 ± 63 μm, p < 0.005), carotid WS (p < 0.005), PWV (p = 0.01), AIx (p < 0.0001) and central PP (p < 0.01) and
lower EPCs (p = 0.02) as compared to controls. RHI was reduced only in diabetic patients with HbA1c ≥7.5% (p < 0.05).
In the overall population, EPCs were an independent determinant of carotid IMT (together with adiponectin), while
fasting plasma glucose was an independent determinant of carotid WS, AIx and central PP.
Conclusions: Our findings suggest that young subjects with relatively long-lasting T1DM have a generalized
preclinical involvement of large artery structure and function, as well as a blunted endothelium regenerating
capacity. Hyperglycemia and suboptimal chronic glycemic control seem to deteriorate the functional arterial
characteristics, such as large arteries stiffness, wave reflection and peripheral endothelium-dependent vasodilation,
whereas an impaired endothelium regenerating capacity and adiponectin levels seem to influence arterial
structure.
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Type 1 diabetes mellitus (T1DM) is a major risk factor for
cardiovascular disease as the incidence of cardiovascular
complications in T1DM patients is reported to be 2- to
10-fold higher than in normal population [1]. Clinically
overt diabetes-related vascular complications are rare in
childhood and adolescence, and an optimal glycemic con-
trol at earlier age and stage of the disease may attenuate
the development and progression of functional and struc-
tural alterations in the arterial tree [2,3]. It is therefore
important to identify preclinical vascular changes at a very
early stage in order to improve glycemic control and
reduce the risk of later cardiovascular complications. A
number of noninvasive measurements, such as endothe-
lium-dependent flow-mediated vasodilation (FMD), com-
mon carotid artery intima-media thickness (C-IMT),
carotid-femoral pulse velocity (PWV, an index of aortic
stiffness) and carotid augmentation index (AIx, an index
of arterial pressure wave reflection) have been proposed as
“tissue biomarkers” capable to improve risk stratification
and tracking early atherosclerotic disease beyond the sim-
ple determination of established risk factors [4].
Endothelial dysfunction has been suggested to anticipate
structural changes in large artery wall in young T1DM
patients [5], in keeping with the hypothesis that functional
abnormalities of the endothelium represent not only an
early marker of atherosclerosis but above all a pathophy-
siologic mechanism promoting the development of arterial
wall thickening and stiffening [6]. This hypothesis was
further confirmed in a recent study on young T1DM
patients [7] that demonstrated a severe impairment of
FMD, important reduction in bone marrow derived circu-
lating endothelial progenitor cells (EPCs), moderate
increase in C-IMT and an inverse relationship between
FMD and C-IMT. C-IMT has been extensively evaluated
in children and adolescents with T1DM, and an increased
C-IMT has been reported not only in subjects with subop-
timal metabolic control [8] but also in those with satisfac-
tory insulin treatment and with a relatively short diabetes
duration (5.5 years) [9-11]. On the other hand, reports
on large artery stiffness in young diabetic patients are still
limited and indirect, based mainly on applanation tonome-
try [12,13].
Various metabolic abnormalities with atherogenic
potential, like fasting and post-prandial high plasma glu-
cose levels, increased advanced glycated endproducts
(AGEs) and post-secretory modified LDL particles, may
be accountable for accelerated development and progres-
sion of vascular organ damage in T1DM [14-17]. The
possible role of adiponectin in T1DM-related vascular
changes [18] requires further elucidation, as plasma levels
of this atheroprotective adipokine have been reported
increased in young peoples with T1DM [19,20].
To identify a sensitive and early marker of vascular
organ damage in T1DM and to provide some insight on
mechanisms underlying these early vascular changes, the
present study compared several different indices of vas-
cular structure and function between T1DM adolescents
and healthy controls of similar age, and it also tested the
relationships between the vascular measures and circulat-
ing EPCs, glyco-metabolic control, serum levels of AGEs,
soluble receptors for AGEs (sRAGE) and adiponectin.
Methods
Study population
We studied 16 consecutive subjects with T1DM and 26
healthy controls. The diabetic population consisted of out-
patients with a relatively long history of disease (11 ± 5
years) undergoing periodic follow-up examinations at the
Pediatric Endocrinology and Diabetes Unit, Pediatrics
Department, University of Pisa. At the time of the study,
they were all taking a combination of rapid-acting, basal
insulin analogs (basal-bolus regimen, optimized according
to clinical evaluation and HbA1c). In all patients, the pre-
sence of concomitant disease (other than diabetes melli-
tus), pharmacological treatment (other than insulin), or
cigarette smoking, alcohol, or food abuse was excluded by
medical history, standard medical examinations and clini-
cal tests. All subjects were free from overt macrovascular
complications, microalbuminuria, retinopathy and neuro-
pathy. The control group of 26 healthy subjects consisted
of friends of the diabetic patients studied and children and
adolescents of Pisa University Hospital staff members. All
females, when fertile, were investigated during the follicu-
lar phase of menstrual cycle.
Study protocol
The protocol of the study followed the principles of the
Declaration of Helsinki and was approved by the institu-
tional ethics committee. All patients (or a parent if minor)
gave their informed consent to participate. Each study par-
ticipant underwent an integrated vascular examination,
two hours after a light breakfast free of caffeine containing
beverages. The same day, venous blood samples were
taken after an overnight fast, between 07.30 and 08.30 am,
in order to measure blood glucose, HbA1c, serum lipids,
circulating EPCs, sRAGE and total circulating adiponectin.
Analytical procedures
Blood glucose, total cholesterol and its fractions, and tri-
glycerides were assayed with standard laboratory meth-
ods. HbA1c was assessed with HPLC (G7 HPLC
Analyzer, Tosoh Bioscience Inc, South San Francisco,
USA; reference range 4.3-6.1%). Circulating total adipo-
nectin was measured with a specific radioimmunoassay
(DRG Diagnostics International Inc, Mountainside, USA;
Palombo et al. Cardiovascular Diabetology 2011, 10:88
http://www.cardiab.com/content/10/1/88
Page 2 of 9sensitivity of 1 ng/ml, an intra- and inter-assay coeffi-
cients of variation of 3.6% and 6.9%, respectively). Circu-
lating soluble receptors of AGEs (sRAGE) levels were
assayed using a commercial ELISA kit (DuoSet ELISA
development kit; R&D Systems, Minneapolis, U.S.A.;
sensitivity of 21.5 pg/ml, an intra- and interassay coeffi-
cients of variation < 6.0% and < 8.5%, respectively).
AGE-dependent skin autofluorescence
AGE-dependent skin autofluorescence (AF) was measured
by the AGE Reader apparatus (DiagnOptics, Groningen,
the Netherlands). In accordance with the manufacturer’s
instructions, measurements were taken at three different
sites on the inner side of the arm, with the subject in a
seated position. AF was expressed in arbitrary units [21].
Quantification of peripheral blood endothelial progenitor
cells (EPCs)
EPCs were analyzed for the expression of surface antigens
with direct two-color flow cytometry (FACS Calibur; BD
Biosciences, Franklin Lakes, NJ, USA). A 100 μLs a m p l eo f
peripheral blood was stained with 10 μL of PERcP-conju-
gated human anti-CD34 monoclonal antibody (mAb) (BD
Biosciences) and 10 μL fluorescein-conjugated anti-human
kinase insert domain receptor (KDR) mAb (R&D Systems,
Minneapolis, MN, USA) or isotype control for 30 minutes
in the dark at 4°C. Red cells were lysed with 1x BD FACS
Lysis solution (BD Pharmigen, UK) and incubated for
5 minutes at room temperature. Samples were analyzed
on a BD FACS Calibur flow cytometer with CellSystems
®
software (Becton Dickinson, UK). The frequency of per-
ipheral blood cells positive for the above reagents was
assessed with a two-dimensional side scatter fluorescence
dot plot analysis, after appropriate gating and staining
with the different reagents: we initially gated CD34
+ per-
ipheral blood cells in the mononuclear cell fraction and
then examined the resulting population for dual expres-
sion of KDR. Validation of the assay was carried out by
the ISHAGE method. For FACS analysis, 5 × 10
5 cells
were acquired. CD34+ cell counts were expressed as a per-
centage of the total gated leukocytes population; CD34
+KDR+ cells (EPCs) were expressed as percentage of total
CD34+ cells. The operator who carried out all the tests
(MC.B.) was trained in flow cytometry, experienced in rare
event analysis and unaware of the participants’ clinical
status.
Integrated vascular investigation
The integrated vascular investigation was performed in a
quiet room, with a stable temperature of 22°, starting
with carotid scanning, after resting comfortably for at
least 15 minutes in supine position. A single operator
(C.M.) unaware of the clinical status of the subject under
investigation performed all vascular recordings and
readings.
Carotid Ultrasound
C a r o t i du l t r a s o u n dw a sp e r f o r m e do nt h er i g h tc a r o t i d
artery using an ultrasound scanner equipped with a linear
10 MHz probe (MyLab 70, Esaote, Genova, Italy) and
implemented with a previously validated radiofrequency-
based tracking of arterial wall that allows a real-time
determination of common carotid far-wall thickness
(QIMT
®) and distension (QAS
®) with high spatial and
temporal resolution [22]. Far-wall IMT (C-IMT) was
automatically measured, and distension curves were
acquired within a carotid segment ~ 1 cm before the flow
divider, where the operator placed the region of interest.
From the distension curves, maximum and minimum
carotid diameters were obtained and indices of vascular
stiffness were calculated after calibration for blood pres-
sure (BP). In this study, we used a “local” carotid wave
speed (WS), calculated from beta-stiffness index (b)a n d
local pulse pressure (PP) according to the following equa-
tions:
1) b stiffness index = ln (systolic BP/diastolic BP)/
ΔD/D, where ΔD is systo-diastolic distension and D
is the end-diastolic diameter [23], and:
2) WS (m/s) = PP/2* b, where PP is local carotid
pulse pressure.
BP was measured at the left brachial artery (Omron,
Kyoto, Japan) during the acquisition of the distension
curves, and brachial PP was rescaled to obtain local carotid
PP from a simultaneously recorded carotid arterial wave-
form by applanation tonometry (see below) [24]. All mea-
sures were averaged over 6 consecutive cardiac beats and
the values used for statistical analysis represent a mean of
three acquisitions. In our laboratory intra-individual varia-
bility of QIMT and QAS measurements are 3.5 ± 1.9 and
5.8 ± 3.4%, respectively.
Carotid Artery Applanation Tonometry
Carotid applanation tonometry was performed on the left
CCA with a validated system (PulsePen, Diatecne, Milan)
[25] simultaneously to the ultrasound investigation, in
order to obtain local PP and AIx, an index of arterial
wave reflection from the periphery [26]. For statistical
analysis, values of AIx averaged through 5 consecutive
heart beats were used. In our laboratory intra-individual
variability of PP and AIx measurements are 4.2 ± 1.7 and
4.9 ± 3.1%, respectively.
Carotid-Femoral Pulse Wave Velocity (PWV)
Carotid-femoral PWV was measured according to cur-
rent guidelines [27]. Briefly, arterial waveforms were
obtained over the right CCA and femoral artery, and the
time delay (t) was measured between the feet of the two
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established as the distance between the two recording
sites. PWV was then calculated as D (meters)/t (seconds).
The measurement was performed three times, using the
Complior device (Alam Medical, Vincennes, France) and
the mean value was used for statistical analysis. Simulta-
n e o u sB Pm e a s u r e m e n tw a sp e r f o r m e da tt h el e f tb r a -
chial artery (Omron, Kyoto, Japan). In our laboratory,
intra-individual variability of PWV measurement is 4.5 ±
2.8%.
Endothelium-Dependent Vasodilation
Peripheral endothelium-dependent vasodilator capacity
was estimated assessing a reactive hyperemia index (RHI)
by means of an EndoPAT system (Itamar Medical Ltd,
Cesarea, Israel) [28]. Briefly, the subject sat in a reclining
chair with the hands at heart level and was propped in a
comfortable position so that the fingers were hanging
freely. Fingertip probes were placed on both index fingers
and pulse wave amplitudes were recorded for the dura-
tion of the entire study that consists of: 5-minute baseline
recording; 5-minute occlusion of non-dominant arm
using a BP cuff inflated to 40 mmHg above systolic pres-
sure; rapid deflation of BP cuff (followed by reactive,
flow-mediated hyperemia) and pulse wave amplitudes
recording for at least further 5 minutes. An integrated
software program compares the ratio of arterial pressure
waves in the two fingers before the occlusion and after
the deflation to calculate the reactive RHI score as the
ratio of the average pulse wave amplitude, measured over
60 seconds starting one min after cuff deflation, to the
average pulse wave amplitude measured at baseline. This
ratio is normalized to the concurrent signal from the
contralateral finger to correct for changes in systemic
vascular tone.
Statistical analysis
Data are expressed as mean ± SD. Variables with a
skewed distribution are given as median [interquartile
range] and were log transformed for use in statistical ana-
lyses. ANOVA was used to compare continuous variables
between T1DM patients and controls. Relationships
between vascular measurements and metabolic para-
meters were evaluated by univariate Pearson’s correlation
coefficients. Multiple regression analysis was then used
to test the independence of these associations. Statistical
tests were two-sided and significance was set at p < 0.05.
Statistical analysis was performed by JMP software, ver-
sion 9.01 (SAS Institute Inc, Cary, NC, USA).
Results
The characteristics of study population are described in
Table 1. After adjustment for sex and age, T1DM and
controls differed only in plasma fasting glucose and not
in plasma lipids, hemodynamic parameters or plasma
adiponectin level. EPCs were significantly decreased in
T 1 D M ,b u tc i r c u l a t i n gs R A G E sa sw e l la ss k i na u t o -
fluorescence values were similar in T1DM and controls.
Mean HbA1c value in our T1DM patients was 7.7 ±
1.1% (range from 5.8 to 10.3%).
Vascular parameters in T1DM and controls are
reported in Figure 1. After adjustment for sex, age and
mean BP, T1DM adolescents had higher central PP, AIx,
carotid-femoral PWV as well as local carotid WS and
C-IMT. Peripheral endothelium-dependent vasodilator
capacity (RHI score) did not differ significantly between
the 2 groups, although it was lower in T1DM patients
with HbA1c ≥7.5% as compared to those with HbA1c <
7.5% (1.5 ± 0.4 vs. 2.2 ± 0.8, p < 0.05) and decreased with
diabetes duration (r = -0.54, p < 0.05).
To identify the metabolic variables accounting for sig-
nificant differences in vascular parameters between
healthy and T1DM young subjects (Figure 1) we tested,
in the entire study population, the univariate associations
of vascular measures with plasma glucose, lipids, adipo-
nectin, AGEs, sRAGEs and EPCs (Table 2). Subsequently,
multiple regression analyses were performed, entering
standardized vascular measures as dependent variables,
and sex, age, mean BP and all metabolic correlates (in
univariate analyses) as independent variables (Table 3).
In univariate analysis, with increasing fasting plasma
glucose increased central PP, AIx, C-F PWV and carotid
WS. With increasing HDL-cholesterol decreased central
PP and C-IMT, whereas with increasing LDL-cholesterol
Table 1 Clinical and Metabolic Characteristics of Study
Population
Controls T1DM p
N2 6 1 6
Sex (males, %) 58 68 = 0.47
Age (years) 19 ± 2 18 ± 2 = 0.12
Body mass index (kg/m
2) 21.6 ± 4.2 21.7 ± 6.2 = 0.82
Systolic BP (mmHg) 112 ± 10 118 ± 16 = 0.13
Diastolic BP (mmHg) 67 ± 5 66 ± 7 = 0.94
Mean BP (mmHg) 82 ± 5 83 ± 8 = 0.47
Heart rate (bpm) 70 ± 12 69 ± 11 = 0.88
Total cholesterol (mg/dL) 165 ± 22 170 ± 33 = 0.37
HDL-cholesterol (mg/dL) 58 ± 13 54 ± 8 = 0.36
LDL-cholesterol (mg/dL) 87 ± 19 100 ± 21 = 0.08
∫Triglycerides (mg/dL) 71 [31] 75 [25] = 0.94
∫Adiponectin (mg/L) 18.5 [5.5] 19.0 [4.5] = 0.09
Fasting plasma glucose (mg/dL) 87 ± 7 178 ± 45 < 0.0001
sRAGEs (pg/ml) 383 ± 152 464 ± 187 = 0.76
AGE-dependent AF (arbitrary units) 1.6 ± 0.3 1.7 ± 0.3 = 0.52
∫EPCs (CD34+/KDR+/10
6 events*) 74 [150] 39 [63] = 0.02
∫: skewed variables expressed as median [interquartile] range; * EPCs: log-
transformed endothelial progenitor cells expressed as CD34+/KDR+ cells/10
6
cytometric events; p values after adjustment for sex and age. Statistically
significant differences are highlighted in bold italic.
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decreased AIx and C-IMT, which was also inversely
related to EPCs (Table 2). Triglycerides, AGEs and
sRAGEs did not correlate with any parameter of vascular
structure or function. In successive multivariate models,
fasting plasma glucose resulted as an independent deter-
minant of central PP, AIx and carotid WS. LDL-choles-
terol was an independent determinant of C-F PWV.
Adiponectin was an inverse and independent correlate of
AIx and C-IMT, and EPCs were inversely and indepen-
dently correlated with C-IMT (Table 3). When diagnosis
of T1DM was included into the multiple regression
model of central PP, AIx and carotid WS, it replaced fast-
ing plasma glucose as an independent determinant of
these vascular measures. In regression model of C-IMT,
T1DM diagnosis replaced EPCs and adiponectin.
We also evaluated the possible inter-relationships
between structural and functional vascular measures. In
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Figure 1 Indices of vascular structure and function in young T1DM patients and healthy controls.C e n t r a lp u l s ep r e s s u r e( P P ) ,
augmentation index (AIx), carotid-femoral pulse wave velocity (C-F PWV), local carotid wave speed (Carotid WS), common carotid artery intima-
media thickness (C-IMT), and reactive hyperemia index (RHI score) in subjects with type 1 diabetes (red) and controls (light blue). Means ± sd are
presented. P values are reported after adjustment for sex, age and mean BP.
Table 2 Univariate Pearson Correlation Coefficients Between Vascular Measures and Metabolic Parameters
Central PP
(mmHg)
AIx
(%)
C-F PWV
(m/s)
Carotid WS
(m/s)
C-IMT
(μm)
RHI score
Fasting plasma glucose r = 0.36 r = 0.47 r = 0.33 r = 0.42 r = 0.29 r = -0.26
(mg/dL) (p < 0.05) (p < 0.005) (p < 0.05) (p < 0.01) (p = 0.06) (p = 0.10)
HDL-cholesterol r = -0.40 r = -0.17 r = -0.16 r = -0.09 r = -0.30 r = 0.24
(mg/dL) (p = 0.01) (p = 0.31) (p = 0.33) (p = 0.59) (p = 0.05) (p = 0.14)
LDL-cholesterol r = 0.06 r = 0.06 r = 0.35 r = 0.26 r = 0.04 r = -0.05
(mg/dL) (p = 0.71) (p = 0.72) (p < 0.05) (p = 0.11) (p = 0.80) (p = 0.77)
∫Adiponectin r = -0.13 r = -0.44 r = -0.01 r = -0.08 r = -0.36 r = 0.24
(mg/L) (p = 0.47) (p < 0.01) (p = 0.96) (p = 0.65) (p < 0.05) (p = 0.16)
∫EPCs r = 0.08 r = -0.27 r = -0.12 r = -0.12 r = -0.31 r = 0.20
(CD34+/KDR+/10
6 events*) (p = 0.63) (p = 0.10) (p = 0.45) (p = 0.46) (p < 0.05) (p = 0.21)
∫: skewed variables log transformed; significant correlations are highlighted in bold italic
Palombo et al. Cardiovascular Diabetology 2011, 10:88
http://www.cardiab.com/content/10/1/88
Page 5 of 9the entire study population, C-IMT was directly related
to AIx, C-F PWV and carotid WS (r = 0.51, 0.30 and
0.31, respectively, p at least < 0.05), and inversely to
RHI score (r = -0.34, p < 0.05)
Discussion
In recent years, particular attention has been paid to the
preclinical alterations in the vascular system in diabetic
children and adolescents in order to prevent development
of overt atherosclerosis and clinical events in the adult-
hood. The high risk of atherosclerosis in diabetes is mainly
attributed to endothelial dysfunction that results both
from endothelial cell damage and impaired endothelial
repair [29]. Bone-marrow derived circulating EPCs are
believed to contribute to endothelial repair, to vascular
homeostasis and to compensatory angiogenesis [30], and
their decrease in diabetes was shown to closely correlate
with the severity of carotid atherosclerosis and progression
of diabetic complications [31,32]. Endothelial dysfunction
is considered not only the first marker of vascular damage
but also a pathophysiologic mechanism promoting further
structural changes within the arterial wall [6].
The results of our study confirm and extend this
hypothesis. Our young T1DM patients free of overt
clinical complications had, as compared to controls of
similar age, a significantly reduced number of specific
Table 3 Independent Correlates of Vascular Parameters: Multiple Regression Model *(b = standardized regression
coefficient)
*b ±S E p
Central PP (mmHg)
Sex (male) 0.57 ± 0.15 p < 0.0005
Age (years) -0.07 ± 0.13 p = 0.60
Mean BP (mmHg) 0.05 ± 0.13 p = 0.69
HDL-cholesterol (mg/dL) -0.01 ± 0.13 p = 0.96
Fasting glucose (mg/dL) 0.29 ± 0.12 p = 0.01
Cumulative R
2 0.54 p < 0.0001
AIx (%)
Sex (male) 0.34 ± 0.16 p < 0.05
Age (years) 0.01 ± 0.15 p = 0.98
Mean BP (mmHg) -0.11 ± 0.16 p = 0.53
Fasting glucose (mg/dL) 0.44 ± 0.14 p < 0.005
∫Adiponectin (mg/L) -0.49 ± 0.14 p < 0.005
Cumulative R
2 0.51 p = 0.0001
C-F PWV (m/s)
Sex (male) 0.39 ± 0.16 p < 0.05
Age (years) 0.30 ± 0.16 p = 0.06
Mean BP (mmHg) 0.07 ± 0.15 p = 0.66
LDL-cholesterol (mg/dL) 0.36 ± 0.16 p < 0.05
Fasting glucose (mg/dL) 0.24 ± 0.19 p = 0.13
Cumulative R
2 0.35 p < 0.01
Carotid WS (m/s)
Sex (male) 0.24 ± 0.16 p = 0.15
Age (years) 0.26 ± 0.16 p = 0.13
Mean BP (mmHg) 0.10 ± 0.16 p = 0.55
Fasting glucose (mg/dL) 0.46 ± 0.16 p < 0.01
Cumulative R
2 0.29 p < 0.05
C-IMT (μm)
Sex (male) 0.49 ± 0.17 p < 0.01
Age (years) 0.39 ± 0.14 p < 0.01
Mean BP (mmHg) 0.14 ± 0.14 p = 0.30
HDL-cholesterol (mg/dL) -0.20 ± 0.15 p = 0.19
∫Adiponectin (mg/L) -0.35 ± 0.13 p = 0.01
∫EPCs -0.48 ± 0.13 p = 0.001
Cumulative R
2 0.57 p < 0.0005
∫: skewed variables log transformed; independent correlates are highlighted in bold italic.
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+KDR
+ EPCs, and, in entire study population,
EPCs count was inversely and independently related to
C-IMT. These findings are in agreement with previous
data in adults [7,33-35], as well as with assumptions
that the abnormalities of endothelial function precede
the development of clinically evident arterial damage
and that an impaired regenerative capacity of the
endothelium yields an increased risk of developing early
atherosclerotic changes [35]. Together with a low EPCs
count, a low plasma adiponectin was another indepen-
dent determinant of increased C-IMT in our young
population. An inhibitory effect of adiponectin against
excessive intimal growth was previously reported in
experimental carotid injury [36], and a large cross-
sectional study in healthy subjects has proposed a low
adiponectin as a risk factor for early atherosclerosis
[37]. Although our data confirmed a protective role of
adiponectin against early carotid atherosclerosis, they
did not confirm the increase in plasma adiponectin
levels in T1DM patient that has been described by
other authors [19,20]. This discrepancy can be explained
by a better glycemic control of our patients, since Barnes
el al. [20] have demonstrated, in a large population of
440 young T1DM subjects, a positive correlation between
adiponectin and HbA1c. Mean HbA1c of our patients
(7.7%) was lower that that of young T1DM subjects
(9.8%), in which an increase in plasma adiponectin levels
has been demonstrated [19].
Chronic glycemic control might also affect endothelial
function. Although RHI score, an index of peripheral
endothelium-dependent vasodilator capacity, was not
decreased in our T1DM patients as compared to con-
trols, it was significantly lower in patients with HbA1c
≥7.5% than in those with HbA1c < 7.5%. Furthermore,
the glycemic control of T1DM children and adolescents
in studies that described an impairment of brachial artery
flow-mediated dilation and microvascular flow-mediated
vasodilatation [7,38,39] was worse than in our group
(HbA1c 8.9, 8.5 and 9.4 vs. 7.7%).
Data on large artery stiffness in children and adoles-
cents with T1DM are more sporadic and report above all
an increase in AIx [12,13]. AIx is an integrated measure
of stiffness and reflection from the periphery, and thus it
does not represent a proper estimate of large artery func-
tion [26]. It has been suggested that an augmented pres-
sure wave reflection in diabetes is a consequence of
combined changes of both small resistance arteries and
large arteries [40]. Increased radial artery AIx has been
demonstrated in T1DM children as young as 10 years of
age [12], and increased carotid artery AIx has been
observed in children and adolescents with relatively short
duration of diabetes (5.4 ± 3.4 years) and poor glycemic
control (HbA1c 9.8%) [41]. Recent data from the
SEARCH of Diabetes in Youth Study have confirmed an
increased AIx in T1DM children together with a decrease
of brachial artery distensibility [42]. In our study, young
T1DM patients showed increased local carotid stiffness,
aortic stiffness and wave reflection, which together
resulted in a significantly higher central pulse pressure
despite similar blood pressure values at brachial artery
level. In addition, in the entire study population, local
carotid stiffness, AIx and pulse pressure were indepen-
dently associated with fasting plasma glucose, a finding
that confirms data regarding the effect of acute hypergly-
cemia on arterial stiffness of T1DM patients [43] and
emphasizes the importance of a strict glycemic control.
Interestingly, carotid-femoral PWV was not indepen-
dently related to plasma glucose but to LDL-cholesterol.
The different impact of metabolic factors on aortic and
carotid stiffness implies that the two vascular districts
may be not interchangeable in predicting cardiometabolic
risk [44].
It must be also taken in consideration that increased
local carotid thickness, stiffness and wave reflection may
ultimately results in a positive feedback loop, promoting
further progression of cardiovascular disease. The altered
local mechanical properties of the carotid artery could
p l a yar o l ei nab a r o r e f l e xg a i nr e d u c t i o nt h a tm a y
increase the susceptibility to develop hypertension [45],
and an increased central pulse pressure may represent a
mechanism accelerating intima-media thickening over
the time [46].
Study limitations
The present study has some limitations. A relatively small
number of subjects included in the two groups does not
exclude that the study could have been underpowered for
some of the subgroup analyses, and it also did not allow
performing the regression analyses between vascular
indices and metabolic variables separately for T1DM
patients and controls. We did not determine AGEs
directly on plasma assays, but used a surrogate noninva-
sive estimate based on skin autofluorescence.
Conclusions
The results of this study suggest that young subjects with
relatively long-lasting T1DM and free of overt clinical
complications, have a significantly lower count of circu-
lating EPCs and a generalized preclinical involvement of
large artery structure and function as compared to
healthy controls. An increase in C-IMT is independently
related to decrease in circulating EPCs and to lower
plasma adiponectin, whereas impairment of peripheral
flow-mediated dilation seems to be associated with worse
chronic glycemic control. Local carotid stiffness and
pressure wave reflection are mainly determined by fasting
plasma glucose, while aortic stiffness is depending on
plasma LDL-cholesterol. From a clinical point of view,
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Page 7 of 9our findings highlight the need of a more strict control of
glycemic levels, considering also the fact that hyperglyce-
m i ar e p r e s e n t sap r i m a r yc o n t r i b u t o rt ot h er e d u c e d
number and impaired function of EPCs in diabetes
[18,30]. Although our T1DM young patients had a better
glycemic control than that found in the adolescent cohort
of the Diabetes Control and Complications Trial (a mean
HbA1c of 8.1%,) [3], various patients showed an average
HbA1c still above the recently indicated target of HbA1c
below 7.5% [47]. Finally the radiofrequency-based track-
ing of arterial wall, which allows an accurate real-time
determination of the basic blood vessel wall properties,
may facilitate and anticipate the detection of early vascu-
lar organ damage in young T1DM subjects [48].
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